These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OXBRIDGE RE HOLDINGS LIMITED
|
|
(Exact
name of registrant as specified in its charter)
|
|
Cayman
Islands
|
|
98-1150254
|
|
(State
or other jurisdiction of
incorporation
or organization)
|
|
(I.R.S.
Employer
Identification
No.)
|
|
Suite
20142 Edward Street, GeorgetownP.O. Box 469
Grand
Cayman, Cayman Islands
|
|
KY1-9006
|
|
(Address
of principal executive offices)
|
|
(Zip
Code)
|
|
Registrant’s
telephone number, including area code: (345) 749-7570
|
|
Yes
☒
|
|
No
☐
|
|
Yes
☒
|
|
No
☐
|
|
Large
accelerated filer ☐
|
|
Accelerated
filer ☐
|
|
Non-accelerated
filer ☐
|
|
Smaller
reporting company ☒
|
|
Emerging growth
company ☒
|
|
|
|
Yes
☐
|
|
No
☒
|
|
PART I – FINANCIAL INFORMATION
|
Page
|
|
|
|
|
|
|
Item
1.
|
Financial
Statements
|
|
|
|
|
|
|
|
Consolidated
Balance Sheets September 30, 2019 (unaudited) and December 31,
2018
|
3
|
|
|
|
|
|
|
Consolidated
Statements of Operations Three and Nine Months Ended September 30,
2019 and 2018 (unaudited)
|
4
|
|
|
|
|
|
|
Consolidated
Statements of Comprehensive (Loss) Income Three and Nine Months
Ended September 30, 2019 and 2018 (unaudited)
|
5
|
|
|
|
|
|
|
Consolidated
Statements of Cash Flows Nine Months Ended September 30, 2019 and
2018 (unaudited)
|
6
|
|
|
|
|
|
|
Consolidated
Statements of Changes in Shareholders’ Equity Three and Nine
Months Ended September 30, 2019 and 2018 (unaudited)
|
8
|
|
|
|
|
|
|
Notes
to Consolidated Financial Statements (unaudited)
|
9
|
|
|
|
|
|
Item
2.
|
Management’s
Discussion and Analysis of Financial Condition and Results of
Operations
|
31
|
|
|
|
|
|
Item
3.
|
Quantitative and
Qualitative Disclosures About Market Risk
|
43
|
|
|
|
|
|
Item
4.
|
Controls and
Procedures
|
43
|
|
|
|
|
|
PART II – OTHER INFORMATION
|
|
|
|
|
|
|
|
Item
1.
|
Legal
Proceedings
|
44
|
|
|
|
|
|
Item
1A.
|
Risk
Factors
|
44
|
|
|
|
|
|
Item
2.
|
Unregistered Sales
of Equity Securities and Use of Proceeds
|
44
|
|
|
|
|
|
Item
3.
|
Defaults Upon
Senior Securities
|
44
|
|
|
|
|
|
Item
4.
|
Mine
Safety Disclosures
|
44
|
|
|
|
|
|
Item
5.
|
Other
Information
|
44
|
|
|
|
|
|
Item
6.
|
Exhibits
|
44
|
|
|
|
|
|
|
Signatures
|
45
|
|
|
At September 30,
2019
|
At December 31,
2018
|
|
|
(Unaudited)
|
|
|
Assets
|
|
|
|
Investments:
|
|
|
|
Fixed-maturity
securities, available for sale, at fair value (amortized cost of
$991 in 2018)
|
$
-
|
993
|
|
Equity securities,
at fair value (cost of $612 and $210 respectively)
|
584
|
162
|
|
Total
investments
|
584
|
1,155
|
|
Cash
and cash equivalents
|
6,137
|
8,074
|
|
Restricted
cash and cash equivalents
|
1,915
|
3,225
|
|
Accrued
interest and dividend receivable
|
11
|
15
|
|
Premiums
receivable
|
837
|
-
|
|
Deferred
policy acquisition costs
|
82
|
-
|
|
Operating
lease right-of-use assets
|
140
|
-
|
|
Prepayment
and other assets
|
73
|
74
|
|
Property
and equipment, net
|
11
|
18
|
|
Total
assets
|
$
9,790
|
12,561
|
|
|
|
|
|
Liabilities and Shareholders’ Equity
|
|
|
|
Liabilities:
|
|
|
|
Reserve
for losses and loss adjustment expenses
|
$
107
|
4,108 #
|
|
Notes
payable to Series 2019-1 noteholders
|
600
|
-
|
|
Unearned
premiums reserve
|
744
|
-
|
|
Operating
lease liabilities
|
140
|
-
|
|
Accounts
payable and other liabilities
|
226
|
139
|
|
Total
liabilities
|
1,817
|
4,247
|
|
|
|
|
|
Shareholders’
equity:
|
|
|
|
Ordinary
share capital, (par value $0.001, 50,000,000 shares authorized;
5,733,587 shares issued and outstanding)
|
6
|
6
|
|
Additional
paid-in capital
|
32,253
|
32,226
|
|
Accumulated
Deficit
|
(24,286
)
|
(23,920
)
|
|
Accumulated
other comprehensive income
|
-
|
2
|
|
Total
shareholders’ equity
|
7,973
|
8,314
|
|
Total
liabilities and shareholders’ equity
|
$
9,790
|
12,561
|
|
|
Three Months Ended
|
Nine Months Ended
|
||
|
|
September 30,
|
September 30,
|
||
|
|
2019
|
2018
|
2019
|
2018
|
|
|
|
|
|
|
|
Revenue
|
|
|
|
|
|
Assumed
premiums
|
$
-
|
47
|
1,116
|
2,627
|
|
Change
in loss experience refund payable
|
-
|
-
|
-
|
(225
)
|
|
Change
in unearned premiums reserve
|
279
|
653
|
(744
)
|
(1,148
)
|
|
|
|
|
|
|
|
Net
premiums earned
|
279
|
700
|
372
|
1,254
|
|
Net
income from derivative instruments
|
-
|
397
|
-
|
773
|
|
Net
investment and other income
|
54
|
100
|
182
|
280
|
|
Net
realized investment losses
|
-
|
(61
)
|
3
|
(237
)
|
|
Change
in fair value of equity securities
|
17
|
118
|
20
|
22
|
|
|
|
|
|
|
|
Total
revenue
|
350
|
1,254
|
577
|
2,092
|
|
|
|
|
|
|
|
Expenses
|
|
|
|
|
|
Net
Loss on commutation
|
-
|
-
|
-
|
8
|
|
Policy
acquisition costs and underwriting expenses
|
31
|
63
|
41
|
101
|
|
General
and administrative expenses
|
264
|
305
|
808
|
981
|
|
|
|
|
|
|
|
Total
expenses
|
295
|
368
|
849
|
1,090
|
|
|
|
|
|
|
|
Income
(loss) before (income) attributable to Series 2019-1
noteholders
|
$
55
|
886
|
(272
)
|
1,002
|
|
|
|
|
|
|
|
(Income)
attributable to Series 2019-1 noteholders
|
(70
)
|
(234
)
|
(94
)
|
(296
)
|
|
|
|
|
|
|
|
Net
(loss) income
|
$
(15
)
|
652
|
(366
)
|
706
|
|
|
|
|
|
|
|
(Loss) Earnings per share
|
|
|
|
|
|
Basic
and Diluted
|
$
(0.00
)
|
0.11
|
(0.06
)
|
0.12
|
|
|
|
|
|
|
|
Dividends paid per share
|
$
-
|
-
|
-
|
-
|
|
|
Three Months Ended
|
Nine Months Ended
|
||
|
|
September 30,
|
September 30,
|
||
|
|
2019
|
2018
|
2019
|
2018
|
|
|
|
|
|
|
|
Net
(loss) income
|
$
(15
)
|
652
|
(366
)
|
706
|
|
Other
comprehensive income (loss):
|
|
|
|
|
|
Change
in unrealized loss on investments:
|
|
|
|
|
|
Unrealized
(loss) gain arising during the period
|
-
|
1
|
1
|
(3
)
|
|
Reclassification
adjustment for net realized losses (gains) included in net (loss)
income
|
-
|
-
|
(3
)
|
-
|
|
|
|
|
|
|
|
Net
change in unrealized loss
|
-
|
1
|
(2
)
|
(3
)
|
|
|
|
|
|
|
|
Total
other comprehensive income (loss)
|
-
|
1
|
(2
)
|
(3
)
|
|
|
|
|
|
|
|
Comprehensive
(loss) income
|
$
(15
)
|
653
|
(368
)
|
703
|
|
|
Nine Months Ended
|
|
|
|
September 30,
|
|
|
|
2019
|
2018
|
|
Operating activities
|
|
|
|
Net
(loss) income
|
$
(366
)
|
706
|
|
Adjustments
to reconcile net (loss) income to net cash used in operating
activities:
|
|
|
|
Stock-based
compensation
|
27
|
94
|
|
Net
amortization of premiums on investments in fixed-maturity
securities
|
-
|
7
|
|
Depreciation
and amortization
|
7
|
14
|
|
Net
realized investment (gains) losses
|
(3
)
|
237
|
|
Change
in fair value of equity securities
|
(20
)
|
(22
)
|
|
Change
in operating assets and liabilities:
|
|
|
|
Accrued
interest and dividend receivable
|
4
|
3
|
|
Premiums
receivable
|
(837
)
|
1,718
|
|
Deferred
policy acquisition costs
|
(82
)
|
(143
)
|
|
Prepayment
and other assets
|
1
|
45
|
|
Reserve
for losses and loss adjustment expenses
|
(4,001
)
|
(4,669
)
|
|
Loss
experience refund payable
|
-
|
(135
)
|
|
Losses
payable
|
-
|
(386
)
|
|
Unearned
premiums reserve
|
744
|
(272
)
|
|
Accounts
payable and other liabilities
|
87
|
589
|
|
|
|
|
|
Net
cash used in operating activities
|
$
(4,439
)
|
(2,214
)
|
|
|
|
|
|
Investing activities
|
|
|
|
Purchase
of fixed-maturity securities
|
-
|
(4,902
)
|
|
Purchase
of equity securities
|
(402
)
|
(5,804
)
|
|
Proceeds
from sale of fixed-maturity and equity securities
|
994
|
12,181
|
|
|
|
|
|
Net
cash provided by investing activities
|
$
592
|
1,475
|
|
|
|
|
|
Financing activities
|
|
|
|
Proceeds
on issuance of notes payable to Series 2019-1
noteholders
|
600
|
2,000
|
|
|
|
|
|
Net
cash provided by financing activities
|
$
600
|
2,000
|
|
|
Nine Months Ended
|
|
|
|
September 30,
|
|
|
|
2019
|
2018
|
|
|
|
|
|
Cash
and cash equivalents, and restricted cash and cash
equivalents:
|
|
|
|
Net
change during the period
|
(3,247
)
|
1,261
|
|
Balance,
beginning of period
|
11,299
|
10,887
|
|
|
|
|
|
Balance,
end of period
|
$
8,052
|
12,148
|
|
|
|
|
|
Supplemental disclosure of cash flow information
|
|
|
|
Interest
paid
|
$
-
|
-
|
|
Income
taxes paid
|
$
-
|
-
|
|
|
|
|
|
Non-cash investing activities
|
|
|
|
Net
change in unrealized loss on securities available for
sale
|
$
(2
)
|
(3
)
|
|
Operating
lease right-of-use assets
|
$
140
|
-
|
|
Operating
lease liability
|
$
140
|
-
|
|
|
Ordinary Share Capital
|
Additional Paid-in
|
Accumulated
|
Accumulated Other Comprehensive
|
Total Shareholders'
|
|
|
|
Shares
|
Amount
|
Capital
|
Deficit
|
Loss
|
Equity
|
|
|
|
|
|
|
|
|
|
Balance at
December 31, 2017
|
5,733,587
|
6
|
32,100
|
(18,149
)
|
(39
)
|
13,918
|
|
Cumulative
effect of change in accounting for equity securities as of January
1, 2018
|
-
|
-
|
-
|
(22
)
|
22
|
-
|
|
Net loss for
the period
|
-
|
-
|
-
|
(211
)
|
-
|
(211
)
|
|
Stock-based
compensation
|
-
|
-
|
31
|
-
|
-
|
31
|
|
Total other
comprehensive loss
|
-
|
-
|
-
|
-
|
(3
)
|
(3
)
|
|
Balance at
March 31, 2018
|
5,733,587
|
6
|
32,131
|
(18,382
)
|
(20
)
|
13,735
|
|
Net income for
the period
|
-
|
-
|
-
|
265
|
-
|
265
|
|
Stock-based
compensation
|
-
|
-
|
32
|
-
|
-
|
32
|
|
Total other
comprehensive loss
|
-
|
-
|
-
|
-
|
(1
)
|
(1
)
|
|
Balance at
June 30, 2018
|
5,733,587
|
6
|
32,163
|
(18,117
)
|
(21
)
|
14,031
|
|
Net income for
the period
|
-
|
-
|
-
|
652
|
-
|
652
|
|
Stock-based
compensation
|
-
|
-
|
31
|
-
|
-
|
31
|
|
Total other
comprehensive income
|
-
|
-
|
-
|
-
|
1
|
1
|
|
Balance at
September 30, 2018
|
5,733,587
|
6
|
32,194
|
(17,465
)
|
(20
)
|
14,715
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at
December 31, 2018
|
5,733,587
|
6
|
32,226
|
(23,920
)
|
2
|
8,314
|
|
Net loss for
the period
|
-
|
-
|
-
|
(146
)
|
-
|
(146
)
|
|
Stock-based
compensation
|
-
|
-
|
9
|
-
|
-
|
9
|
|
Total other
comprehensive loss
|
-
|
-
|
-
|
-
|
(2
)
|
(2
)
|
|
Balance at
March 31, 2019
|
5,733,587
|
6
|
32,235
|
(24,066
)
|
-
|
8,175
|
|
Net loss for
the period
|
-
|
-
|
-
|
(205
)
|
-
|
(205
)
|
|
Stock-based
compensation
|
-
|
-
|
9
|
-
|
-
|
9
|
|
Balance at
June 30, 2019
|
5,733,587
|
6
|
32,244
|
(24,271
)
|
-
|
7,979
|
|
Net loss for
the period
|
-
|
-
|
-
|
(15
)
|
-
|
(15
)
|
|
Stock-based
compensation
|
-
|
-
|
9
|
-
|
-
|
9
|
|
Balance at
September 30, 2019
|
5,733,587
|
6
|
32,253
|
(24,286
)
|
-
|
7,973
|
|
Level
1
|
Inputs
that reflect unadjusted quoted prices in active markets for
identical assets or liabilities that the Company has the ability to
access at the measurement date;
|
|
|
|
|
Level
2
|
Inputs
other than quoted prices that are observable for the asset or
liability either directly or indirectly, including inputs in
markets that are not considered to be active; and
|
|
|
|
|
Level
3
|
Inputs
that are unobservable.
|
|
|
At September 30,
|
At December 31,
|
|
|
2019
|
2018
|
|
|
(in thousands)
|
|
|
|
|
|
|
Cash
on deposit
|
$
3,468
|
$
3,965
|
|
Cash
held with custodians
|
2,669
|
4,109
|
|
Restricted
cash held in trust
|
1,915
|
3,225
|
|
|
|
|
|
Total
|
$
8,052
|
$
11,299
|
|
|
Cost
or
Amortized
Cost
|
Gross
Unrealized
Gain
|
Gross
Unrealized
Loss
|
Estimated
Fair
Value
($000)
|
|
|
($ in
thousands)
|
|||
|
As of December 31, 2018
|
|
|
|
|
|
Fixed-maturity securities
|
|
|
|
|
|
U.S. Treasury and
agency securities
|
$
991
|
$
2
|
$
-
|
$
993
|
|
|
Gross proceeds
from sales
|
Gross
Realized
Gains
|
Gross
Realized
Losses
|
|
|
($ in
thousands)
|
||
|
|
|
|
|
|
Nine Months Ended September 30, 2019
|
|
|
|
|
Available-for-sale
fixed-maturity securities
|
$
994
|
$
3
|
$
-
|
|
|
|
|
|
|
Three Months Ended September 30, 2018
|
|
|
|
|
Available-for-sale
fixed-maturity securities
|
$
1,565
|
$
3
|
$
-
|
|
|
|
|
|
|
Equity
securities
|
$
1,583
|
$
57
|
$
(121
)
|
|
|
|
|
|
|
Nine Months Ended September 30, 2018
|
|
|
|
|
Available-for-sale
fixed-maturity securities
|
$
4,565
|
$
3
|
$
-
|
|
|
|
|
|
|
Equity
securities
|
$
7,616
|
$
475
|
$
(715
)
|
|
|
Fair Value
Measurements Using
|
|
||
|
|
(Level
1)
|
(Level
2)
|
(Level
3)
|
Total
|
|
As of September 30, 2019
|
($ in
thousands)
|
|||
|
Financial
Assets:
|
|
|
|
|
|
Cash and cash equivalents
|
$
6,137
|
$
-
|
$
-
|
$
6,137
|
|
|
|
|
|
|
|
Restricted cash and cash equivalents
|
$
1,915
|
$
-
|
$
-
|
$
1,915
|
|
|
|
|
|
|
|
Total
equity securities
|
584
|
-
|
-
|
584
|
|
|
|
|
|
|
|
Total
|
$
8,636
|
$
-
|
$
-
|
$
8,636
|
|
|
Fair Value
Measurements Using
|
|
||
|
|
(Level
1)
|
(Level
2)
|
(Level
3)
|
Total
|
|
As of December 31, 2018
|
($ in
thousands)
|
|||
|
Financial
Assets:
|
|
|
|
|
|
Cash and cash equivalents
|
$
8,074
|
$
-
|
$
-
|
$
8,074
|
|
|
|
|
|
|
|
Restricted cash and cash equivalents
|
$
3,225
|
$
-
|
$
-
|
$
3,225
|
|
|
|
|
|
|
|
U.S. Treasury and
agency securities
|
-
|
993
|
-
|
993
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
fixed-maturity securities
|
-
|
993
|
-
|
993
|
|
|
|
|
|
|
|
Total equity
securities
|
162
|
-
|
-
|
162
|
|
|
|
|
|
|
|
Total available for
sale securities
|
162
|
993
|
-
|
1,155
|
|
|
|
|
|
|
|
Total
|
$
11,461
|
$
993
|
$
-
|
$
12,454
|
|
|
Three Months Ended
|
Nine Months Ended
|
||
|
|
September 30,
|
September 30,
|
||
|
|
2019
|
2018
|
2019
|
2018
|
|
|
($ in thousands)
|
($ in thousands)
|
||
|
|
|
|
|
|
|
Balance,
beginning of period
|
$
107
|
167
|
$
4,108
|
4,836
|
|
Incurred
related to:
|
|
|
|
|
|
Current
period
|
-
|
-
|
-
|
-
|
|
Prior period
1
|
-
|
-
|
-
|
(1,012
)
|
|
Total
incurred
|
-
|
-
|
-
|
(1,012
)
|
|
Paid
related to:
|
|
|
|
|
|
Current
period
|
-
|
-
|
-
|
-
|
|
Prior
period
|
-
|
-
|
(4,001
)
|
(3,657
)
|
|
Total
paid
|
-
|
-
|
(4,001
)
|
(3,657
)
|
|
Net
balance, end of period
|
$
107
|
167
|
$
107
|
167
|
|
Add:
reinsurance recoverable
|
-
|
-
|
-
|
-
|
|
Gross
balance, end of period
|
$
107
|
167
|
$
107
|
167
|
|
|
Three Months Ended
|
Nine Months Ended
|
||
|
|
September 30,
|
September 30,
|
||
|
|
2019
|
2018
|
2019
|
2018
|
|
|
|
|
|
|
|
Numerator:
|
|
|
|
|
|
Net
(loss) earnings
|
$
(15
)
|
652
|
$
(366
)
|
706
|
|
|
|
|
|
|
|
Denominator:
|
|
|
|
|
|
Weighted
average shares - basic
|
5,733,587
|
5,733,587
|
5,733,587
|
5,733,587
|
|
Effect
of dilutive securities - Stock options
|
-
|
-
|
-
|
-
|
|
Shares
issuable upon conversion of warrants
|
-
|
-
|
-
|
-
|
|
Weighted
average shares - diluted
|
5,733,587
|
5,733,587
|
5,733,587
|
5,733,587
|
|
(Loss)/earnings
per shares - basic
|
$
(0.00
)
|
0.11
|
$
(0.06
)
|
0.12
|
|
(Loss)/earnings
per shares - diluted
|
$
(0.00
)
|
0.11
|
$
(0.06
)
|
0.12
|
|
|
Number
of
Options
|
Weighted-
Average
Exercise
Price
|
Weighted-
Average
Remaining
Contractual
Term
|
Aggregate
Intrinsic
Value
|
|
|
|
|
|
|
|
Outstanding
at January 1, 2019
|
250,000
|
|
|
|
|
Granted
|
290,000
|
$
2.00
|
|
|
|
Outstanding
at March 31, 2019
|
540,000
|
$
3.86
|
8.1
years
|
$
-
|
|
Outstanding
at June 30, 2019
|
540,000
|
$
3.86
|
7.9
years
|
$
-
|
|
Outstanding
at September 30, 2019
|
540,000
|
$
3.86
|
7.6
years
|
$
-
|
|
Exercisable
at September 30, 2019
|
291,250
|
$
5.26
|
6.3
years
|
$
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding
at January 1, 2018
|
250,000
|
$
6.01
|
|
|
|
Outstanding
at March 31, 2018
|
250,000
|
$
6.01
|
7.2
years
|
$
-
|
|
Outstanding
at June 30, 2018
|
250,000
|
$
6.01
|
6.9
years
|
$
-
|
|
Outstanding
at September 30, 2018
|
250,000
|
$
6.01
|
6.7
years
|
$
-
|
|
Exercisable
at September 30, 2018
|
208,125
|
$
6.01
|
6.7
years
|
$
-
|
|
|
2019
|
|
|
|
|
Expected
dividend yield
|
0
%
|
|
Expected
volatility
|
31
%
|
|
Risk-free
interest rate
|
3
%
|
|
Expected
life (in years)
|
10
|
|
Per
share grant date fair value of options issued
|
$
0.36
|
|
|
For the
Three-Month Period
|
For the
Nine-Month Period
|
|
(in thousands)
|
Ended
September 30, 2019
|
Ended
September 30, 2019
|
|
Operating Lease Cost
(1)
|
$
22
|
$
63
|
|
|
|
|
|
Cash
paid for amounts included in the measurement of lease
liabilities
|
|
|
|
Operating
cash flows from operating leases
|
$
22
|
$
71
|
|
|
|
|
|
(1)
Includes short-term
leases
|
|
|
|
(in thousands)
|
At September 30,
2019
|
|
Operating
lease right-of-use assets
|
$
140
|
|
|
|
|
Operating
lease liabilities
|
$
140
|
|
|
|
|
Weighted-average
remaining lease term - operating leases
|
4.42
years
|
|
|
|
|
Weighted-average
discount rate - operating leases
|
6.5
%
|
|
(in thousands)
|
At September 30,
2019
|
At December 31,
2018
|
|
Remainder
of 2019
|
$
9
|
$
-
|
|
2020
|
36
|
-
|
|
2021
|
36
|
-
|
|
2022
|
37
|
-
|
|
2023
|
37
|
-
|
|
Thereafter
|
6
|
-
|
|
Total
future minimum lease payments
|
$
161
|
$
-
|
|
|
|
|
|
Less
imputed interest
|
(21
)
|
N/A
|
|
Total
operating lease liability
|
$
140
|
N/A
|
|
|
Three Months Ended
|
Nine Months Ended
|
||
|
|
September 30,
|
September 30,
|
||
|
|
2019
|
2018
|
2019
|
2018
|
|
|
(in thousands)
|
(in thousands)
|
||
|
|
|
|
|
|
|
Revenue
|
|
|
|
|
|
Assumed
premiums
|
-
|
-
|
-
|
-
|
|
Change
in loss experience refund payable
|
-
|
-
|
-
|
(225
)
|
|
Change
in unearned premiums reserve
|
-
|
-
|
-
|
592
|
|
|
Three Months Ended
|
Nine Months Ended
|
||
|
|
September 30,
|
September 30,
|
||
|
|
2019
|
2018
|
2019
|
2018
|
|
|
(unaudited)
|
(unaudited)
|
||
|
|
|
|
|
|
|
Revenue
|
|
|
|
|
|
Assumed
premiums
|
$
-
|
47
|
1,116
|
2,627
|
|
Change
in loss experience refund payable
|
-
|
-
|
-
|
(225
)
|
|
Change
in unearned premiums reserve
|
279
|
653
|
(744
)
|
(1,148
)
|
|
|
|
|
|
|
|
Net
premiums earned
|
279
|
700
|
372
|
1,254
|
|
Net
income from derivative instruments
|
-
|
397
|
-
|
773
|
|
Net
investment and other income
|
54
|
100
|
182
|
280
|
|
Net
realized investment gains(losses)
|
-
|
(61
)
|
3
|
(237
)
|
|
Change
in fair value of equity securities
|
17
|
118
|
20
|
22
|
|
|
|
|
|
|
|
Total
revenue
|
350
|
1,254
|
577
|
2,092
|
|
|
|
|
|
|
|
Expenses
|
|
|
|
|
|
Net
loss on commutation
|
-
|
-
|
-
|
8
|
|
Policy
acquisition costs and underwriting expenses
|
31
|
63
|
41
|
101
|
|
General
and administrative expenses
|
264
|
305
|
808
|
981
|
|
|
|
|
|
|
|
Total
expenses
|
295
|
368
|
849
|
1,090
|
|
|
|
|
|
|
|
Income
(loss) before (income) attributable to Series 2019-1
noteholders
|
$
55
|
886
|
(272
)
|
1,002
|
|
|
|
|
|
|
|
(Income)
attributable to Series 2019-1 noteholders
|
(70
)
|
(234
)
|
(94
)
|
(296
)
|
|
|
|
|
|
|
|
Net
(loss) income
|
$
(15
)
|
652
|
(366
)
|
706
|
|
|
|
|
|
|
|
(Loss) Earnings per share
|
|
|
|
|
|
Basic
and Diluted
|
$
(0.00
)
|
0.11
|
(0.06
)
|
0.12
|
|
|
|
|
|
|
|
Dividends paid per share
|
$
-
|
-
|
-
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Performance
ratios to net premiums earned:
|
|
|
|
|
|
Loss
ratio
|
0.0
%
|
0.0
%
|
0.0
%
|
0.0
%
|
|
Acquisition
cost ratio
|
11.1
%
|
9.0
%
|
11.0
%
|
8.1
%
|
|
Expense
ratio
|
105.7
%
|
33.5
%
|
228.2
%
|
53.8
%
|
|
Combined
ratio
|
105.7
%
|
33.5
%
|
228.2
%
|
53.8
%
|
|
Exhibit No.
|
|
Document
|
|
|
|
|
|
|
Certifications
of the Chief Executive Officer pursuant to Section 302 of the
Sarbanes-Oxley Act and Rule 13a-14(a) or 15d-14(a) under the
Securities Exchange Act of 1934.
|
|
|
|
|
|
|
|
Certifications
of the Chief Financial Officer pursuant to Section 302 of the
Sarbanes-Oxley Act and Rule 13a-14(a) or 15d-14(a) under the
Securities Exchange Act of 1934.
|
|
|
|
|
|
|
|
Written
Statement of the Chief Executive Officer and Chief Financial
Officer pursuant to 18 U.S.C. §1350.
|
|
|
|
|
|
|
101
|
|
The
following materials from Oxbridge Re Holdings Limited’s
Quarterly Report on Form 10-Q for the quarter ended September 30,
2019 are filed herewith, formatted in XBRL (Extensible Business
Reporting Language): (i) the Consolidated Balance Sheets, (ii) the
Consolidated Statements of Operations, (iii) the Consolidated
Statements of Comprehensive Income, (iv) the Consolidated
Statements of Cash Flows, (v) the Consolidated Statements of
Changes in Shareholders’ Equity and (vi) the Notes to
Consolidated Financial Statements.
|
|
|
OXBRIDGE
RE HOLDINGS LIMITED
|
|
|
|
|
|
|
|
|
Date: November 4,
2019
|
By:
|
/s/
JAY
MADHU
|
|
|
|
|
Jay
Madhu
|
|
|
|
|
Chief Executive
Officer and President
(Principal
Executive Officer)
|
|
|
Date: November 4,
2019
|
By:
|
/s/
WRENDON
TIMOTHY
|
|
|
|
|
Wrendon
Timothy
|
|
|
|
|
Chief Financial
Officer and Secretary
(Principal
Financial Officer and Principal Accounting
Officer)
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|